SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Signify Health, Inc. – ‘10-Q’ for 3/31/21 – ‘EX-101.CAL’

On:  Wednesday, 5/12/21, at 4:46pm ET   ·   For:  3/31/21   ·   Accession #:  1828182-21-17   ·   File #:  1-40028

Previous ‘10-Q’:  None   ·   Next:  ‘10-Q’ on 8/11/21 for 6/30/21   ·   Latest:  ‘10-Q’ on 11/8/22 for 9/30/22

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 5/12/21  Signify Health, Inc.              10-Q        3/31/21   94:7.7M

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    754K 
 2: EX-10.1     Material Contract                                   HTML     68K 
 3: EX-10.2     Material Contract                                   HTML     67K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     27K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     27K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     25K 
 7: EX-32.2     Certification -- §906 - SOA'02                      HTML     25K 
14: R1          Cover Page                                          HTML     78K 
15: R2          Condensed Consolidated Balance Sheets               HTML    153K 
16: R3          Consolidated Balance Sheets (Parenthetical)         HTML     32K 
17: R4          Condensed Consolidated Statements of Operations     HTML    111K 
18: R5          Condensed Consolidated Statements of Changes in     HTML     73K 
                Stockholders' / Members? Equity                                  
19: R6          Condensed Consolidated Statements of Cash Flows     HTML    126K 
20: R7          Nature of Operations                                HTML     34K 
21: R8          Significant Accounting Policies                     HTML     55K 
22: R9          The COVID-19 Pandemic                               HTML     33K 
23: R10         Variable Interest Entities                          HTML     45K 
24: R11         Revenue Recognition                                 HTML     96K 
25: R12         Property and Equipment                              HTML     36K 
26: R13         Intangible Assets                                   HTML     46K 
27: R14         Accounts Payable and Accrued Expenses               HTML     34K 
28: R15         Long-Term Debt                                      HTML     44K 
29: R16         Fair Value Measurements                             HTML     82K 
30: R17         Shareholders' Equity                                HTML     38K 
31: R18         Noncontrolling Interest                             HTML     31K 
32: R19         Equity-Based Compensation                           HTML     36K 
33: R20         Loss Per Share                                      HTML     35K 
34: R21         Transaction-related Expenses                        HTML     26K 
35: R22         Commitment and Contingencies                        HTML     40K 
36: R23         Income Taxes                                        HTML     34K 
37: R24         Segment Reporting                                   HTML     56K 
38: R25         Concentrations                                      HTML     27K 
39: R26         Related Party Transactions                          HTML     30K 
40: R27         Significant Accounting Policies (Policies)          HTML     74K 
41: R28         Significant Accounting Policies (Tables)            HTML     40K 
42: R29         Variable Interest Entities (Tables)                 HTML     47K 
43: R30         Revenue Recognition (Tables)                        HTML     93K 
44: R31         Property and Equipment (Tables)                     HTML     35K 
45: R32         Intangible Assets (Tables)                          HTML     47K 
46: R33         Accounts Payable and Accrued Expenses (Tables)      HTML     34K 
47: R34         Long-Term Debt (Tables)                             HTML     46K 
48: R35         Fair Value Measurements (Tables)                    HTML     86K 
49: R36         Noncontrolling Interest (Tables)                    HTML     30K 
50: R37         Loss Per Share (Tables)                             HTML     32K 
51: R38         Commitment and Contingencies (Tables)               HTML     29K 
52: R39         Segment Reporting (Tables)                          HTML     50K 
53: R40         Nature of Operations (Details)                      HTML     54K 
54: R41         Significant Accounting Policies - Narrative         HTML     47K 
                (Details)                                                        
55: R42         Significant Accounting Policies - Cash, Cash        HTML     33K 
                Equivalents and Restricted Cash (Details)                        
56: R43         Variable Interest Entities - Narrative (Details)    HTML     38K 
57: R44         Variable Interest Entities - Schedule of Variable   HTML     86K 
                Interest Entities (Details)                                      
58: R45         Revenue Recognition - Narrative (Details)           HTML     26K 
59: R46         Revenue Recognition - Disaggregation of Revenue     HTML     40K 
                (Details)                                                        
60: R47         Revenue Recognition - Schedule of Related Balance   HTML     54K 
                Sheets Account (Details)                                         
61: R48         Revenue Recognition - Contract Assets (Details)     HTML     28K 
62: R49         Revenue Recognition - Contract Liabilities          HTML     32K 
                (Details)                                                        
63: R50         Revenue Recognition - Deferred Revenue (Details)    HTML     30K 
64: R51         Revenue Recognition - Shared Savings Payable        HTML     29K 
                (Details)                                                        
65: R52         Property and Equipment - Property and Equipment,    HTML     43K 
                net (Details)                                                    
66: R53         Property and Equipment - Narrative (Details)        HTML     28K 
67: R54         Intangible Assets - Schedule of Intangible Assets   HTML     44K 
                (Details)                                                        
68: R55         Intangible Assets - Narrative (Details)             HTML     30K 
69: R56         Intangible Assets - Schedule of Expected            HTML     39K 
                Amortization Expense (Details)                                   
70: R57         Accounts Payable and Accrued Expenses (Details)     HTML     39K 
71: R58         Long-Term Debt - Schedule of Long-Term Debt         HTML     48K 
                (Details)                                                        
72: R59         Long-Term Debt - Narrative (Details)                HTML     44K 
73: R60         Long-Term Debt - Future Principal Maturities of     HTML     37K 
                Long-Term Debt (Details)                                         
74: R61         Fair Value Measurements - Schedule of Assets and    HTML     46K 
                Liabilities Measured at Fair Value on a Recurring                
                Basis (Details)                                                  
75: R62         Fair Value Measurements - Changes in Contingent     HTML     40K 
                Consideration and Customer Equity Appreciation                   
                Rights (Details)                                                 
76: R63         Fair Value Measurements - Schedule of Valuation     HTML     55K 
                Techniques and Significant Unobservable Inputs                   
                (Details)                                                        
77: R64         Shareholders' Equity (Details)                      HTML     48K 
78: R65         Noncontrolling Interest (Details)                   HTML     39K 
79: R66         Equity-Based Compensation (Details)                 HTML     94K 
80: R67         Loss Per Share - Schedule of Earnings (Loss) Per    HTML     70K 
                Share (Details)                                                  
81: R68         Loss Per Share - Narrative (Details)                HTML     34K 
82: R69         Transaction-related Expenses - Narrative (Details)  HTML     31K 
83: R70         Commitment and Contingencies - Narrative (Details)  HTML     65K 
84: R71         Commitment and Contingencies - Summary of SEU       HTML     35K 
                Activity (Details)                                               
85: R72         Income Taxes (Details)                              HTML     49K 
86: R73         Segment Reporting - Narrative (Details)             HTML     25K 
87: R74         Segment Reporting - Schedule of Operating Segment   HTML     69K 
                Results (Details)                                                
88: R75         Concentrations (Details)                            HTML     43K 
89: R76         Related Party Transactions (Details)                HTML     38K 
90: R9999       Uncategorized Items - sgfy-20210331.htm             HTML     80K 
92: XML         IDEA XML File -- Filing Summary                      XML    165K 
13: XML         XBRL Instance -- sgfy-20210331_htm                   XML   1.68M 
91: EXCEL       IDEA Workbook of Financial Reports                  XLSX    112K 
 9: EX-101.CAL  XBRL Calculations -- sgfy-20210331_cal               XML    236K 
10: EX-101.DEF  XBRL Definitions -- sgfy-20210331_def                XML    727K 
11: EX-101.LAB  XBRL Labels -- sgfy-20210331_lab                     XML   1.59M 
12: EX-101.PRE  XBRL Presentations -- sgfy-20210331_pre              XML   1.03M 
 8: EX-101.SCH  XBRL Schema -- sgfy-20210331                         XSD    183K 
93: JSON        XBRL Instance as JSON Data -- MetaLinks              402±   573K 
94: ZIP         XBRL Zipped Folder -- 0001828182-21-000017-xbrl      Zip    318K

‘EX-101.CAL’   —   XBRL Calculations — sgfy-20210331_cal

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- XBRL Document Created with Wdesk from Workiva -->
<!-- Copyright 2021 Workiva -->
<!-- r:d6107ef6-a450-4acc-b922-3c2f157d639a,g:974e82ca-822f-4b29-91ba-d43c06f684ef -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://signifyhealth.com/role/CoverPage" xlink:type="simple" xlink:href="sgfy-20210331.xsd#CoverPage"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/CoverPage" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="sgfy-20210331.xsd#CondensedConsolidatedBalanceSheets"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_33dc116b-4b08-4dbd-abef-3a74971f46b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_e581748f-2178-4140-8eea-d77aa486daba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_33dc116b-4b08-4dbd-abef-3a74971f46b0" xlink:to="loc_us-gaap_Liabilities_e581748f-2178-4140-8eea-d77aa486daba" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_d345776e-8b96-4fb6-a2b3-ab879b4b6230" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_33dc116b-4b08-4dbd-abef-3a74971f46b0" xlink:to="loc_us-gaap_CommitmentsAndContingencies_d345776e-8b96-4fb6-a2b3-ab879b4b6230" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dd9b7ce1-174c-44bd-a979-d33b2cc2a914" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_33dc116b-4b08-4dbd-abef-3a74971f46b0" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dd9b7ce1-174c-44bd-a979-d33b2cc2a914" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f653a0ea-3b68-43e0-95b6-1f4df93ce9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_454f69cf-400f-42b5-ac38-5b3ac09be99b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f653a0ea-3b68-43e0-95b6-1f4df93ce9a4" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_454f69cf-400f-42b5-ac38-5b3ac09be99b" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_620591b9-67ee-4a62-bdab-ff0ec0551e14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f653a0ea-3b68-43e0-95b6-1f4df93ce9a4" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_620591b9-67ee-4a62-bdab-ff0ec0551e14" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_f2ea41d4-cce2-4341-b234-d0e815918914" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f653a0ea-3b68-43e0-95b6-1f4df93ce9a4" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_f2ea41d4-cce2-4341-b234-d0e815918914" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2cbbb391-b471-47b4-b856-fe66f28948d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f653a0ea-3b68-43e0-95b6-1f4df93ce9a4" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2cbbb391-b471-47b4-b856-fe66f28948d0" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_211b3ac2-e67f-4ce2-9340-4c470efa169d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
<link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f653a0ea-3b68-43e0-95b6-1f4df93ce9a4" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_211b3ac2-e67f-4ce2-9340-4c470efa169d" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_24a76a6a-372b-4a7c-9a50-ef2d3ab6ac67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
<link:loc xlink:type="locator" xlink:label="loc_sgfy_StockAppreciationRightsLiability_709374b8-2cf3-4290-85ac-e233684a780d" xlink:href="sgfy-20210331.xsd#sgfy_StockAppreciationRightsLiability"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_24a76a6a-372b-4a7c-9a50-ef2d3ab6ac67" xlink:to="loc_sgfy_StockAppreciationRightsLiability_709374b8-2cf3-4290-85ac-e233684a780d" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_8589ba66-59c4-49c2-91d0-9cf2308e5393" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_24a76a6a-372b-4a7c-9a50-ef2d3ab6ac67" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_8589ba66-59c4-49c2-91d0-9cf2308e5393" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_7954941d-0303-46a4-a4c0-76d775398481" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_24a76a6a-372b-4a7c-9a50-ef2d3ab6ac67" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_7954941d-0303-46a4-a4c0-76d775398481" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_27e88f28-e2a2-4622-a3ee-ad8386ba5f79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_24a76a6a-372b-4a7c-9a50-ef2d3ab6ac67" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_27e88f28-e2a2-4622-a3ee-ad8386ba5f79" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesNoncurrent_a8996455-5503-4d69-ac95-b279b46d29bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesNoncurrent"/>
<link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_24a76a6a-372b-4a7c-9a50-ef2d3ab6ac67" xlink:to="loc_us-gaap_DueToRelatedPartiesNoncurrent_a8996455-5503-4d69-ac95-b279b46d29bb" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_4bb7d009-faaf-4b1d-8514-d6736553bbc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
<link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_24a76a6a-372b-4a7c-9a50-ef2d3ab6ac67" xlink:to="loc_us-gaap_LiabilitiesCurrent_4bb7d009-faaf-4b1d-8514-d6736553bbc5" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_80b57253-4bf1-47c4-b46a-ba4f1a859963" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
<link:loc xlink:type="locator" xlink:label="loc_sgfy_DeferredIncomeTaxLiabilitiesNetCurrent_374a0ae7-1d30-4a5b-b37b-55d2d9d176dc" xlink:href="sgfy-20210331.xsd#sgfy_DeferredIncomeTaxLiabilitiesNetCurrent"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_80b57253-4bf1-47c4-b46a-ba4f1a859963" xlink:to="loc_sgfy_DeferredIncomeTaxLiabilitiesNetCurrent_374a0ae7-1d30-4a5b-b37b-55d2d9d176dc" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_5e60b121-23c4-4ed1-bfe9-55265ddad8f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_80b57253-4bf1-47c4-b46a-ba4f1a859963" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_5e60b121-23c4-4ed1-bfe9-55265ddad8f1" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent_d513b115-85ac-448a-b2e8-362fe65cef9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerRefundLiabilityCurrent"/>
<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_80b57253-4bf1-47c4-b46a-ba4f1a859963" xlink:to="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent_d513b115-85ac-448a-b2e8-362fe65cef9a" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_3e445120-93dc-4a48-b583-93fe9996217d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_80b57253-4bf1-47c4-b46a-ba4f1a859963" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_3e445120-93dc-4a48-b583-93fe9996217d" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_c54da4e8-93fd-4536-ba10-d71dfe0785fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
<link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_80b57253-4bf1-47c4-b46a-ba4f1a859963" xlink:to="loc_us-gaap_LongTermDebtCurrent_c54da4e8-93fd-4536-ba10-d71dfe0785fb" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_77908599-772e-4ba5-ab31-9ea1981dc253" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
<link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_80b57253-4bf1-47c4-b46a-ba4f1a859963" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_77908599-772e-4ba5-ab31-9ea1981dc253" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_68dc8165-844a-4cc0-9141-cbadd3b76f44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ec038e1d-7ee0-4b1b-bb8c-d409f04306ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_68dc8165-844a-4cc0-9141-cbadd3b76f44" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_ec038e1d-7ee0-4b1b-bb8c-d409f04306ad" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_873e5dc8-7c67-42db-802d-15100a7f0b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_68dc8165-844a-4cc0-9141-cbadd3b76f44" xlink:to="loc_us-gaap_AssetsCurrent_873e5dc8-7c67-42db-802d-15100a7f0b5b" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b3cf5718-db86-45bd-ad13-6105cd4f3fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_68dc8165-844a-4cc0-9141-cbadd3b76f44" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b3cf5718-db86-45bd-ad13-6105cd4f3fe9" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7737263d-b820-45b8-9d0b-44c11ec19df8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_68dc8165-844a-4cc0-9141-cbadd3b76f44" xlink:to="loc_us-gaap_Goodwill_7737263d-b820-45b8-9d0b-44c11ec19df8" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_3870a847-73f3-411e-8ef5-bcc38258eaf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
<link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_68dc8165-844a-4cc0-9141-cbadd3b76f44" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_3870a847-73f3-411e-8ef5-bcc38258eaf4" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_2335de85-693d-4841-a284-6b55026a8578" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
<link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_68dc8165-844a-4cc0-9141-cbadd3b76f44" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_2335de85-693d-4841-a284-6b55026a8578" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5e5c50f3-68dd-436e-b0fc-b8e24d1cf66c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_35212fec-a594-4901-8a27-dfdeda865696" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5e5c50f3-68dd-436e-b0fc-b8e24d1cf66c" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_35212fec-a594-4901-8a27-dfdeda865696" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_5e2848b0-7e8d-4765-8711-4c48517c196b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5e5c50f3-68dd-436e-b0fc-b8e24d1cf66c" xlink:to="loc_us-gaap_CommonStockValue_5e2848b0-7e8d-4765-8711-4c48517c196b" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_7d918f90-9a99-46c5-a108-c7c7a9546a14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5e5c50f3-68dd-436e-b0fc-b8e24d1cf66c" xlink:to="loc_us-gaap_MinorityInterest_7d918f90-9a99-46c5-a108-c7c7a9546a14" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_73955d9a-97b6-4f76-9ecb-2306ebc9ef0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5e5c50f3-68dd-436e-b0fc-b8e24d1cf66c" xlink:to="loc_us-gaap_AdditionalPaidInCapital_73955d9a-97b6-4f76-9ecb-2306ebc9ef0f" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_MembersEquity_b0caca99-5df4-457a-b7b7-dc61855c53f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MembersEquity"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_707d6919-2d1a-468e-bafb-93bf03538187" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MembersEquity_b0caca99-5df4-457a-b7b7-dc61855c53f3" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_707d6919-2d1a-468e-bafb-93bf03538187" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_3b652f90-2921-4ea2-96f7-7bb1b7b1afb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MembersEquity_b0caca99-5df4-457a-b7b7-dc61855c53f3" xlink:to="loc_us-gaap_AdditionalPaidInCapital_3b652f90-2921-4ea2-96f7-7bb1b7b1afb5" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_MembersCapital_b70785c6-40da-4863-8107-4bdbb9e148b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MembersCapital"/>
<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MembersEquity_b0caca99-5df4-457a-b7b7-dc61855c53f3" xlink:to="loc_us-gaap_MembersCapital_b70785c6-40da-4863-8107-4bdbb9e148b7" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_51eda3ea-1c12-4b77-a0d6-475fb46e9fe4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MembersEquity_b0caca99-5df4-457a-b7b7-dc61855c53f3" xlink:to="loc_us-gaap_MinorityInterest_51eda3ea-1c12-4b77-a0d6-475fb46e9fe4" xlink:type="arc"/>
</link:calculationLink>
<link:roleRef roleURI="http://signifyhealth.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="sgfy-20210331.xsd#ConsolidatedBalanceSheetsParenthetical"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="sgfy-20210331.xsd#CondensedConsolidatedStatementsofOperations"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_df829a21-a778-4257-b2e4-7b83da1e30f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_132db0d3-8fda-4259-9163-f0ce7ecb1711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_df829a21-a778-4257-b2e4-7b83da1e30f5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_132db0d3-8fda-4259-9163-f0ce7ecb1711" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e43a24ff-977e-4cd9-b6a6-5e5df1a4d234" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
<link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_df829a21-a778-4257-b2e4-7b83da1e30f5" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e43a24ff-977e-4cd9-b6a6-5e5df1a4d234" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_de458127-c07a-477d-a4d3-2210fb69199a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_6aaed236-fafd-4091-9135-63795836363c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_de458127-c07a-477d-a4d3-2210fb69199a" xlink:to="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_6aaed236-fafd-4091-9135-63795836363c" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a73ff76c-4be5-49a4-8bd1-bbe8fa3e260c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_de458127-c07a-477d-a4d3-2210fb69199a" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a73ff76c-4be5-49a4-8bd1-bbe8fa3e260c" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_sgfy_TransactionRelatedExpenses_b85671aa-79b4-49d8-92f7-6ed4875da018" xlink:href="sgfy-20210331.xsd#sgfy_TransactionRelatedExpenses"/>
<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_de458127-c07a-477d-a4d3-2210fb69199a" xlink:to="loc_sgfy_TransactionRelatedExpenses_b85671aa-79b4-49d8-92f7-6ed4875da018" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_bb338d70-5b72-4a91-9e7a-8cf555783a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization"/>
<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_de458127-c07a-477d-a4d3-2210fb69199a" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_bb338d70-5b72-4a91-9e7a-8cf555783a9a" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9a47d014-825f-4142-ac3e-23dd30aaf7bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_15f46dd9-7370-4d13-9b9d-60eabeaa54cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_9a47d014-825f-4142-ac3e-23dd30aaf7bc" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_15f46dd9-7370-4d13-9b9d-60eabeaa54cc" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_70adf41b-b196-4f44-b274-dda2ff420983" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
<link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_9a47d014-825f-4142-ac3e-23dd30aaf7bc" xlink:to="loc_us-gaap_CostsAndExpenses_70adf41b-b196-4f44-b274-dda2ff420983" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1a161178-8c82-417b-bbd2-58d8ef631d40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3263057f-7e77-4841-b3a9-9e176264cf13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_1a161178-8c82-417b-bbd2-58d8ef631d40" xlink:to="loc_us-gaap_ProfitLoss_3263057f-7e77-4841-b3a9-9e176264cf13" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_b83ac71d-0487-4e4d-af15-fb3ad7636e96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
<link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_1a161178-8c82-417b-bbd2-58d8ef631d40" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_b83ac71d-0487-4e4d-af15-fb3ad7636e96" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_7037f2cb-bd86-4441-8adf-b1a6839f47e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_8e484f26-ca83-4285-bd05-3dd0b0a345d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
<link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_7037f2cb-bd86-4441-8adf-b1a6839f47e1" xlink:to="loc_us-gaap_InterestExpense_8e484f26-ca83-4285-bd05-3dd0b0a345d3" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ffa869ed-08f7-42d4-94dd-3c833442bdf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_7037f2cb-bd86-4441-8adf-b1a6839f47e1" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ffa869ed-08f7-42d4-94dd-3c833442bdf7" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d26c57fa-3664-49fb-8fda-72b08177dbd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d5b58a00-1d93-4c7f-99a7-3766c072be69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d26c57fa-3664-49fb-8fda-72b08177dbd3" xlink:to="loc_us-gaap_OperatingIncomeLoss_d5b58a00-1d93-4c7f-99a7-3766c072be69" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_9f835248-5475-47cc-9512-f1e6c4c60e36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d26c57fa-3664-49fb-8fda-72b08177dbd3" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_9f835248-5475-47cc-9512-f1e6c4c60e36" xlink:type="arc"/>
</link:calculationLink>
<link:roleRef roleURI="http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity" xlink:type="simple" xlink:href="sgfy-20210331.xsd#CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/CondensedConsolidatedStatementsofChangesinStockholdersMembersEquity" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="sgfy-20210331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d488ea86-4f5c-486c-9b77-001a2dac3984" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
<link:loc xlink:type="locator" xlink:label="loc_sgfy_FairValueAdjustmentOfShareBasedCompensationAgreementGrantedForServices_7fbbd50b-1aca-4f0f-93d4-c3b87cb8ab53" xlink:href="sgfy-20210331.xsd#sgfy_FairValueAdjustmentOfShareBasedCompensationAgreementGrantedForServices"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d488ea86-4f5c-486c-9b77-001a2dac3984" xlink:to="loc_sgfy_FairValueAdjustmentOfShareBasedCompensationAgreementGrantedForServices_7fbbd50b-1aca-4f0f-93d4-c3b87cb8ab53" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_ae462cdf-a073-46c5-8282-1550d0435014" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d488ea86-4f5c-486c-9b77-001a2dac3984" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_ae462cdf-a073-46c5-8282-1550d0435014" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_994b7677-d3a7-4c1c-951d-53fd4c38b438" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d488ea86-4f5c-486c-9b77-001a2dac3984" xlink:to="loc_us-gaap_ShareBasedCompensation_994b7677-d3a7-4c1c-951d-53fd4c38b438" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b521f35d-0e70-4c4f-8fb0-4b40dccecd5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
<link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d488ea86-4f5c-486c-9b77-001a2dac3984" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b521f35d-0e70-4c4f-8fb0-4b40dccecd5e" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_9ce2d99c-39eb-4c11-9953-42c4c2a0ba49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
<link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d488ea86-4f5c-486c-9b77-001a2dac3984" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_9ce2d99c-39eb-4c11-9953-42c4c2a0ba49" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_0d8db9fc-44f2-4b9f-87b5-45da534cc337" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
<link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d488ea86-4f5c-486c-9b77-001a2dac3984" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_0d8db9fc-44f2-4b9f-87b5-45da534cc337" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_afe0b83f-b68a-433c-969b-15a44bf77f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
<link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d488ea86-4f5c-486c-9b77-001a2dac3984" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_afe0b83f-b68a-433c-969b-15a44bf77f3b" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ffcfebfe-f18a-4c71-ad4d-9275b462d97d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
<link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d488ea86-4f5c-486c-9b77-001a2dac3984" xlink:to="loc_us-gaap_ProfitLoss_ffcfebfe-f18a-4c71-ad4d-9275b462d97d" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_f4e9cdc3-acfc-4443-85af-6fa43cc0c21a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
<link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d488ea86-4f5c-486c-9b77-001a2dac3984" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_f4e9cdc3-acfc-4443-85af-6fa43cc0c21a" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_eec3e696-7371-46b1-a707-e7c7d2ac67d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
<link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d488ea86-4f5c-486c-9b77-001a2dac3984" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_eec3e696-7371-46b1-a707-e7c7d2ac67d3" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_196ba0d5-e297-4a2f-bc67-61a843b4a792" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
<link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d488ea86-4f5c-486c-9b77-001a2dac3984" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_196ba0d5-e297-4a2f-bc67-61a843b4a792" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_d78c8c4d-72d2-4a87-8d52-e91b8e9ca09a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
<link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d488ea86-4f5c-486c-9b77-001a2dac3984" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_d78c8c4d-72d2-4a87-8d52-e91b8e9ca09a" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_22cf88eb-50fe-42ab-84ab-8cf0a8bc6197" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
<link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d488ea86-4f5c-486c-9b77-001a2dac3984" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_22cf88eb-50fe-42ab-84ab-8cf0a8bc6197" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_e8581874-0b57-47fc-b03c-45d8dd13d5ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
<link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d488ea86-4f5c-486c-9b77-001a2dac3984" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_e8581874-0b57-47fc-b03c-45d8dd13d5ee" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_96098a52-fae6-4221-8531-d6ce1aa9707d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
<link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d488ea86-4f5c-486c-9b77-001a2dac3984" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_96098a52-fae6-4221-8531-d6ce1aa9707d" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_b74f49e2-7b41-4182-922a-b2869db8a0b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
<link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d488ea86-4f5c-486c-9b77-001a2dac3984" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_b74f49e2-7b41-4182-922a-b2869db8a0b2" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_e331bad4-0a82-430f-bd49-4cfa9124d7f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
<link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d488ea86-4f5c-486c-9b77-001a2dac3984" xlink:to="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_e331bad4-0a82-430f-bd49-4cfa9124d7f5" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_baa8c483-4227-4715-9b28-d338390eb056" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForSoftware_5991f5d2-35c0-415f-a718-f2106ee97c96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForSoftware"/>
<link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_baa8c483-4227-4715-9b28-d338390eb056" xlink:to="loc_us-gaap_PaymentsForSoftware_5991f5d2-35c0-415f-a718-f2106ee97c96" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0eddb839-3dc9-45e4-b4d4-0d532fbcc5c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
<link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_baa8c483-4227-4715-9b28-d338390eb056" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0eddb839-3dc9-45e4-b4d4-0d532fbcc5c5" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cb79d93a-0376-4c45-b2a7-4376943542f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cdf981ed-5cf2-489d-988b-9c7030e1baf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cb79d93a-0376-4c45-b2a7-4376943542f0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_cdf981ed-5cf2-489d-988b-9c7030e1baf5" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_af189c38-4c31-4cdd-8486-bcd9342ecc5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cb79d93a-0376-4c45-b2a7-4376943542f0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_af189c38-4c31-4cdd-8486-bcd9342ecc5c" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_02969286-e7d0-48ca-870d-c7de98dbe750" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cb79d93a-0376-4c45-b2a7-4376943542f0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_02969286-e7d0-48ca-870d-c7de98dbe750" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7d94d9f1-7b92-4e8e-8427-6fe656098e65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
<link:loc xlink:type="locator" xlink:label="loc_sgfy_ProceedsFromIncomeTaxRefundsFromAffiliate_c57d8c7b-f835-4d25-9024-837c3bed095b" xlink:href="sgfy-20210331.xsd#sgfy_ProceedsFromIncomeTaxRefundsFromAffiliate"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7d94d9f1-7b92-4e8e-8427-6fe656098e65" xlink:to="loc_sgfy_ProceedsFromIncomeTaxRefundsFromAffiliate_c57d8c7b-f835-4d25-9024-837c3bed095b" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_c8fe7581-87f9-4bb8-a509-92448bf1b03a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
<link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7d94d9f1-7b92-4e8e-8427-6fe656098e65" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_c8fe7581-87f9-4bb8-a509-92448bf1b03a" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_967064f1-fcb4-4429-800f-aace9d928f16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
<link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7d94d9f1-7b92-4e8e-8427-6fe656098e65" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_967064f1-fcb4-4429-800f-aace9d928f16" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_af04aca3-7f51-42c3-bc79-441498c96a96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7d94d9f1-7b92-4e8e-8427-6fe656098e65" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_af04aca3-7f51-42c3-bc79-441498c96a96" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_5c4209e0-5826-44e6-8e7a-f357cbc04756" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
<link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7d94d9f1-7b92-4e8e-8427-6fe656098e65" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_5c4209e0-5826-44e6-8e7a-f357cbc04756" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_859b483d-b3e1-48bc-adbf-b9bf1d7fa6ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
<link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7d94d9f1-7b92-4e8e-8427-6fe656098e65" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_859b483d-b3e1-48bc-adbf-b9bf1d7fa6ce" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt_5e3e797c-0982-49a2-a33e-5a8bfffcd34b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
<link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7d94d9f1-7b92-4e8e-8427-6fe656098e65" xlink:to="loc_us-gaap_RepaymentsOfOtherLongTermDebt_5e3e797c-0982-49a2-a33e-5a8bfffcd34b" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_8ea030bb-312e-422f-ba58-909efeb2a069" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
<link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7d94d9f1-7b92-4e8e-8427-6fe656098e65" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_8ea030bb-312e-422f-ba58-909efeb2a069" xlink:type="arc"/>
</link:calculationLink>
<link:roleRef roleURI="http://signifyhealth.com/role/NatureofOperations" xlink:type="simple" xlink:href="sgfy-20210331.xsd#NatureofOperations"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/NatureofOperations" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/NatureofOperationsDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#NatureofOperationsDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/NatureofOperationsDetails" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="sgfy-20210331.xsd#SignificantAccountingPolicies"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/SignificantAccountingPolicies" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="sgfy-20210331.xsd#SignificantAccountingPoliciesPolicies"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/SignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="sgfy-20210331.xsd#SignificantAccountingPoliciesTables"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/SignificantAccountingPoliciesTables" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/SignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#SignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/SignificantAccountingPoliciesCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_97a0d51a-aed0-4168-be45-2da8325af08d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_2c7712ad-0735-4c27-bfdf-8c9e7a771f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_97a0d51a-aed0-4168-be45-2da8325af08d" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_2c7712ad-0735-4c27-bfdf-8c9e7a771f4e" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3aa46296-99b8-4c1a-935e-1cd3ca5ae579" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_97a0d51a-aed0-4168-be45-2da8325af08d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3aa46296-99b8-4c1a-935e-1cd3ca5ae579" xlink:type="arc"/>
</link:calculationLink>
<link:roleRef roleURI="http://signifyhealth.com/role/TheCOVID19Pandemic" xlink:type="simple" xlink:href="sgfy-20210331.xsd#TheCOVID19Pandemic"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/TheCOVID19Pandemic" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/VariableInterestEntities" xlink:type="simple" xlink:href="sgfy-20210331.xsd#VariableInterestEntities"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/VariableInterestEntities" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/VariableInterestEntitiesTables" xlink:type="simple" xlink:href="sgfy-20210331.xsd#VariableInterestEntitiesTables"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/VariableInterestEntitiesTables" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/VariableInterestEntitiesNarrativeDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#VariableInterestEntitiesNarrativeDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/VariableInterestEntitiesNarrativeDetails" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/VariableInterestEntitiesScheduleofVariableInterestEntitiesDetails" xlink:type="extended">
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_78b655a7-66ee-4481-ae2c-a39079328502" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_489ecc62-c3cc-4205-9b0b-5babdd03d069" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_78b655a7-66ee-4481-ae2c-a39079328502" xlink:to="loc_us-gaap_AdditionalPaidInCapital_489ecc62-c3cc-4205-9b0b-5babdd03d069" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_44fd81d4-1fce-400b-acec-0e2d367b9fde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_78b655a7-66ee-4481-ae2c-a39079328502" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_44fd81d4-1fce-400b-acec-0e2d367b9fde" xlink:type="arc"/>
</link:calculationLink>
<link:roleRef roleURI="http://signifyhealth.com/role/RevenueRecognition" xlink:type="simple" xlink:href="sgfy-20210331.xsd#RevenueRecognition"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/RevenueRecognition" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/RevenueRecognitionTables" xlink:type="simple" xlink:href="sgfy-20210331.xsd#RevenueRecognitionTables"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/RevenueRecognitionTables" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/RevenueRecognitionNarrativeDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#RevenueRecognitionNarrativeDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/RevenueRecognitionNarrativeDetails" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/RevenueRecognitionDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#RevenueRecognitionDisaggregationofRevenueDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/RevenueRecognitionDisaggregationofRevenueDetails" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/RevenueRecognitionScheduleofRelatedBalanceSheetsAccountDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#RevenueRecognitionScheduleofRelatedBalanceSheetsAccountDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/RevenueRecognitionScheduleofRelatedBalanceSheetsAccountDetails" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/RevenueRecognitionContractAssetsDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#RevenueRecognitionContractAssetsDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/RevenueRecognitionContractAssetsDetails" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/RevenueRecognitionContractLiabilitiesDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#RevenueRecognitionContractLiabilitiesDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/RevenueRecognitionContractLiabilitiesDetails" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/RevenueRecognitionDeferredRevenueDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#RevenueRecognitionDeferredRevenueDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/RevenueRecognitionDeferredRevenueDetails" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/RevenueRecognitionSharedSavingsPayableDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#RevenueRecognitionSharedSavingsPayableDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/RevenueRecognitionSharedSavingsPayableDetails" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/PropertyandEquipment" xlink:type="simple" xlink:href="sgfy-20210331.xsd#PropertyandEquipment"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/PropertyandEquipment" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/PropertyandEquipmentTables" xlink:type="simple" xlink:href="sgfy-20210331.xsd#PropertyandEquipmentTables"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/PropertyandEquipmentTables" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/PropertyandEquipmentPropertyandEquipmentnetDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#PropertyandEquipmentPropertyandEquipmentnetDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/PropertyandEquipmentPropertyandEquipmentnetDetails" xlink:type="extended">
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_4a887157-adb2-49eb-b8a8-d46073e29261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_b3542bc6-3926-4010-b4cb-2fd40287558d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
<link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_4a887157-adb2-49eb-b8a8-d46073e29261" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_b3542bc6-3926-4010-b4cb-2fd40287558d" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_850fe44e-29c1-450b-a722-d3f60e41db2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_4a887157-adb2-49eb-b8a8-d46073e29261" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_850fe44e-29c1-450b-a722-d3f60e41db2b" xlink:type="arc"/>
</link:calculationLink>
<link:roleRef roleURI="http://signifyhealth.com/role/PropertyandEquipmentNarrativeDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#PropertyandEquipmentNarrativeDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/PropertyandEquipmentNarrativeDetails" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/IntangibleAssets" xlink:type="simple" xlink:href="sgfy-20210331.xsd#IntangibleAssets"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/IntangibleAssets" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/IntangibleAssetsTables" xlink:type="simple" xlink:href="sgfy-20210331.xsd#IntangibleAssetsTables"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/IntangibleAssetsTables" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/IntangibleAssetsScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#IntangibleAssetsScheduleofIntangibleAssetsDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/IntangibleAssetsScheduleofIntangibleAssetsDetails" xlink:type="extended">
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9da41a4a-3a8e-4b93-a33a-9916f2c33675" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ad1cc8a6-613a-4f21-8d00-d212b045fcbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9da41a4a-3a8e-4b93-a33a-9916f2c33675" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ad1cc8a6-613a-4f21-8d00-d212b045fcbf" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d5c2e449-700f-4c9f-b75f-1935cba8ca1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
<link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9da41a4a-3a8e-4b93-a33a-9916f2c33675" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d5c2e449-700f-4c9f-b75f-1935cba8ca1b" xlink:type="arc"/>
</link:calculationLink>
<link:roleRef roleURI="http://signifyhealth.com/role/IntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#IntangibleAssetsNarrativeDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/IntangibleAssetsNarrativeDetails" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/IntangibleAssetsScheduleofExpectedAmortizationExpenseDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#IntangibleAssetsScheduleofExpectedAmortizationExpenseDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/IntangibleAssetsScheduleofExpectedAmortizationExpenseDetails" xlink:type="extended">
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_93f460b7-8d7a-4f2c-a15f-de6a2efc4232" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_56b7a2b6-dbe5-400d-ae6c-181ee14337a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_93f460b7-8d7a-4f2c-a15f-de6a2efc4232" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_56b7a2b6-dbe5-400d-ae6c-181ee14337a2" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_f8419587-a73e-431d-b8b6-4b2eb6667074" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_93f460b7-8d7a-4f2c-a15f-de6a2efc4232" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_f8419587-a73e-431d-b8b6-4b2eb6667074" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_da018fbe-27b7-48ed-ace7-40b86479b0a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_93f460b7-8d7a-4f2c-a15f-de6a2efc4232" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_da018fbe-27b7-48ed-ace7-40b86479b0a8" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_sgfy_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_c0da7993-a58d-40d8-99e9-c1e5874ba0e0" xlink:href="sgfy-20210331.xsd#sgfy_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_93f460b7-8d7a-4f2c-a15f-de6a2efc4232" xlink:to="loc_sgfy_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_c0da7993-a58d-40d8-99e9-c1e5874ba0e0" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_b37aec26-d6a3-4540-888f-ebff7ab14ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
<link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_93f460b7-8d7a-4f2c-a15f-de6a2efc4232" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_b37aec26-d6a3-4540-888f-ebff7ab14ee1" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_00cf8590-4c97-4e28-ab64-aa078baf49a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
<link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_93f460b7-8d7a-4f2c-a15f-de6a2efc4232" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_00cf8590-4c97-4e28-ab64-aa078baf49a9" xlink:type="arc"/>
</link:calculationLink>
<link:roleRef roleURI="http://signifyhealth.com/role/AccountsPayableandAccruedExpenses" xlink:type="simple" xlink:href="sgfy-20210331.xsd#AccountsPayableandAccruedExpenses"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/AccountsPayableandAccruedExpenses" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/AccountsPayableandAccruedExpensesTables" xlink:type="simple" xlink:href="sgfy-20210331.xsd#AccountsPayableandAccruedExpensesTables"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/AccountsPayableandAccruedExpensesTables" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/AccountsPayableandAccruedExpensesDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#AccountsPayableandAccruedExpensesDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/AccountsPayableandAccruedExpensesDetails" xlink:type="extended">
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_e07d9b07-e28b-4469-b445-7c6229ea0318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_e53f0258-b292-4a75-b3f4-44e6e8db25ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_e07d9b07-e28b-4469-b445-7c6229ea0318" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_e53f0258-b292-4a75-b3f4-44e6e8db25ba" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxes_bcec2e2e-c2ae-4122-b28b-5fc0fc0ee9c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxes"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_e07d9b07-e28b-4469-b445-7c6229ea0318" xlink:to="loc_us-gaap_AccruedIncomeTaxes_bcec2e2e-c2ae-4122-b28b-5fc0fc0ee9c1" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_sgfy_SharedSavingsPayable_01b4f4c3-eeba-41bc-afd2-11b65a6a090b" xlink:href="sgfy-20210331.xsd#sgfy_SharedSavingsPayable"/>
<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_e07d9b07-e28b-4469-b445-7c6229ea0318" xlink:to="loc_sgfy_SharedSavingsPayable_01b4f4c3-eeba-41bc-afd2-11b65a6a090b" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrentAndNoncurrent_d026e0fc-2ca4-4a0a-b509-7b97b5bd4c64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent"/>
<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_e07d9b07-e28b-4469-b445-7c6229ea0318" xlink:to="loc_us-gaap_AccountsPayableCurrentAndNoncurrent_d026e0fc-2ca4-4a0a-b509-7b97b5bd4c64" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_d4334649-4f3b-407e-9db6-e5a460bd79df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent"/>
<link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_e07d9b07-e28b-4469-b445-7c6229ea0318" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_d4334649-4f3b-407e-9db6-e5a460bd79df" xlink:type="arc"/>
</link:calculationLink>
<link:roleRef roleURI="http://signifyhealth.com/role/LongTermDebt" xlink:type="simple" xlink:href="sgfy-20210331.xsd#LongTermDebt"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/LongTermDebt" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="sgfy-20210331.xsd#LongTermDebtTables"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/LongTermDebtTables" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#LongTermDebtScheduleofLongTermDebtDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/LongTermDebtScheduleofLongTermDebtDetails" xlink:type="extended">
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_95bc5062-3089-49cd-bd6d-482ce8ba061c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_deb83d9d-467f-481c-9d63-247a7b00f783" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_95bc5062-3089-49cd-bd6d-482ce8ba061c" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_deb83d9d-467f-481c-9d63-247a7b00f783" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_54d31716-fb98-4722-8e4a-0d68a063397b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_95bc5062-3089-49cd-bd6d-482ce8ba061c" xlink:to="loc_us-gaap_LongTermDebtCurrent_54d31716-fb98-4722-8e4a-0d68a063397b" xlink:type="arc"/>
</link:calculationLink>
<link:roleRef roleURI="http://signifyhealth.com/role/LongTermDebtScheduleofLongTermDebtDetails_1" xlink:type="simple" xlink:href="sgfy-20210331.xsd#LongTermDebtScheduleofLongTermDebtDetails_1"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/LongTermDebtScheduleofLongTermDebtDetails_1" xlink:type="extended">
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_0a4b2943-5aa9-4da0-814f-5a27f0f34667" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_59f5459a-a2e1-4aae-ac08-55e3f8d3defa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_0a4b2943-5aa9-4da0-814f-5a27f0f34667" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_59f5459a-a2e1-4aae-ac08-55e3f8d3defa" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_a2e0080a-21a2-45c3-8cfe-43302b85a6ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
<link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_0a4b2943-5aa9-4da0-814f-5a27f0f34667" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_a2e0080a-21a2-45c3-8cfe-43302b85a6ac" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_8de82824-0555-4863-aa37-7492a9d42179" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
<link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_0a4b2943-5aa9-4da0-814f-5a27f0f34667" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_8de82824-0555-4863-aa37-7492a9d42179" xlink:type="arc"/>
</link:calculationLink>
<link:roleRef roleURI="http://signifyhealth.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#LongTermDebtNarrativeDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/LongTermDebtNarrativeDetails" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/LongTermDebtFuturePrincipalMaturitiesofLongTermDebtDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#LongTermDebtFuturePrincipalMaturitiesofLongTermDebtDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/LongTermDebtFuturePrincipalMaturitiesofLongTermDebtDetails" xlink:type="extended">
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_ea6ec89e-a820-4596-811e-78968fc5c9ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_f801bb06-68d1-4630-8c0a-c1a44c38bf9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_ea6ec89e-a820-4596-811e-78968fc5c9ac" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_f801bb06-68d1-4630-8c0a-c1a44c38bf9b" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_4eafeaea-a4b3-4384-99ba-c2a047858f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_ea6ec89e-a820-4596-811e-78968fc5c9ac" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_4eafeaea-a4b3-4384-99ba-c2a047858f9e" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_99191e36-09a2-43e7-a4d0-ef03841bdc6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_ea6ec89e-a820-4596-811e-78968fc5c9ac" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_99191e36-09a2-43e7-a4d0-ef03841bdc6b" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_61a612c8-3b99-4bc8-9136-a2f2038771d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_ea6ec89e-a820-4596-811e-78968fc5c9ac" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_61a612c8-3b99-4bc8-9136-a2f2038771d5" xlink:type="arc"/>
</link:calculationLink>
<link:roleRef roleURI="http://signifyhealth.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="sgfy-20210331.xsd#FairValueMeasurements"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/FairValueMeasurements" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="sgfy-20210331.xsd#FairValueMeasurementsTables"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/FairValueMeasurementsTables" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/FairValueMeasurementsChangesinContingentConsiderationandCustomerEquityAppreciationRightsDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#FairValueMeasurementsChangesinContingentConsiderationandCustomerEquityAppreciationRightsDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/FairValueMeasurementsChangesinContingentConsiderationandCustomerEquityAppreciationRightsDetails" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/FairValueMeasurementsScheduleofValuationTechniquesandSignificantUnobservableInputsDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#FairValueMeasurementsScheduleofValuationTechniquesandSignificantUnobservableInputsDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/FairValueMeasurementsScheduleofValuationTechniquesandSignificantUnobservableInputsDetails" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/ShareholdersEquity" xlink:type="simple" xlink:href="sgfy-20210331.xsd#ShareholdersEquity"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/ShareholdersEquity" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/ShareholdersEquityDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#ShareholdersEquityDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/ShareholdersEquityDetails" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/NoncontrollingInterest" xlink:type="simple" xlink:href="sgfy-20210331.xsd#NoncontrollingInterest"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/NoncontrollingInterest" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/NoncontrollingInterestTables" xlink:type="simple" xlink:href="sgfy-20210331.xsd#NoncontrollingInterestTables"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/NoncontrollingInterestTables" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/NoncontrollingInterestDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#NoncontrollingInterestDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/NoncontrollingInterestDetails" xlink:type="extended">
<link:loc xlink:type="locator" xlink:label="loc_sgfy_NoncontrollingInterestOwnershipPercentage_5ca5e956-53b3-4e1c-915d-d6acb415455f" xlink:href="sgfy-20210331.xsd#sgfy_NoncontrollingInterestOwnershipPercentage"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_c3a4ffb0-da08-4568-99b2-36fcb70621ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sgfy_NoncontrollingInterestOwnershipPercentage_5ca5e956-53b3-4e1c-915d-d6acb415455f" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_c3a4ffb0-da08-4568-99b2-36fcb70621ff" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_b00fb90d-91db-420d-8f9c-823fa190e7e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
<link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sgfy_NoncontrollingInterestOwnershipPercentage_5ca5e956-53b3-4e1c-915d-d6acb415455f" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_b00fb90d-91db-420d-8f9c-823fa190e7e6" xlink:type="arc"/>
</link:calculationLink>
<link:roleRef roleURI="http://signifyhealth.com/role/EquityBasedCompensation" xlink:type="simple" xlink:href="sgfy-20210331.xsd#EquityBasedCompensation"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/EquityBasedCompensation" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/EquityBasedCompensationDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#EquityBasedCompensationDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/EquityBasedCompensationDetails" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/LossPerShare" xlink:type="simple" xlink:href="sgfy-20210331.xsd#LossPerShare"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/LossPerShare" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/LossPerShareTables" xlink:type="simple" xlink:href="sgfy-20210331.xsd#LossPerShareTables"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/LossPerShareTables" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/LossPerShareScheduleofEarningsLossPerShareDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#LossPerShareScheduleofEarningsLossPerShareDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/LossPerShareScheduleofEarningsLossPerShareDetails" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/LossPerShareNarrativeDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#LossPerShareNarrativeDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/LossPerShareNarrativeDetails" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/TransactionrelatedExpenses" xlink:type="simple" xlink:href="sgfy-20210331.xsd#TransactionrelatedExpenses"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/TransactionrelatedExpenses" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/TransactionrelatedExpensesNarrativeDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#TransactionrelatedExpensesNarrativeDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/TransactionrelatedExpensesNarrativeDetails" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/CommitmentandContingencies" xlink:type="simple" xlink:href="sgfy-20210331.xsd#CommitmentandContingencies"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/CommitmentandContingencies" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/CommitmentandContingenciesTables" xlink:type="simple" xlink:href="sgfy-20210331.xsd#CommitmentandContingenciesTables"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/CommitmentandContingenciesTables" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/CommitmentandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#CommitmentandContingenciesNarrativeDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/CommitmentandContingenciesNarrativeDetails" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/CommitmentandContingenciesSummaryofSEUActivityDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#CommitmentandContingenciesSummaryofSEUActivityDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/CommitmentandContingenciesSummaryofSEUActivityDetails" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/IncomeTaxes" xlink:type="simple" xlink:href="sgfy-20210331.xsd#IncomeTaxes"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/IncomeTaxes" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#IncomeTaxesDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/IncomeTaxesDetails" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/SegmentReporting" xlink:type="simple" xlink:href="sgfy-20210331.xsd#SegmentReporting"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/SegmentReporting" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="sgfy-20210331.xsd#SegmentReportingTables"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/SegmentReportingTables" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/SegmentReportingNarrativeDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#SegmentReportingNarrativeDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/SegmentReportingNarrativeDetails" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#SegmentReportingScheduleofOperatingSegmentResultsDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/SegmentReportingScheduleofOperatingSegmentResultsDetails" xlink:type="extended">
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ec4d7272-2c75-4007-b69a-0abf550a39c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
<link:loc xlink:type="locator" xlink:label="loc_sgfy_SegmentAdjustedEBITDA_1ca35aae-36db-4348-a06a-a947ba2f5628" xlink:href="sgfy-20210331.xsd#sgfy_SegmentAdjustedEBITDA"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ec4d7272-2c75-4007-b69a-0abf550a39c8" xlink:to="loc_sgfy_SegmentAdjustedEBITDA_1ca35aae-36db-4348-a06a-a947ba2f5628" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_9b1a5af1-db2c-4abd-b9a5-141b8deba9ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
<link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ec4d7272-2c75-4007-b69a-0abf550a39c8" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_9b1a5af1-db2c-4abd-b9a5-141b8deba9ae" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_sgfy_UnallocatedCostsAndExpenses_c5f625fa-8d62-47b3-8458-76fd11df1734" xlink:href="sgfy-20210331.xsd#sgfy_UnallocatedCostsAndExpenses"/>
<link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ec4d7272-2c75-4007-b69a-0abf550a39c8" xlink:to="loc_sgfy_UnallocatedCostsAndExpenses_c5f625fa-8d62-47b3-8458-76fd11df1734" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_4a4e2d76-810e-43b7-baec-c801c91dd5f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
<link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ec4d7272-2c75-4007-b69a-0abf550a39c8" xlink:to="loc_us-gaap_InterestExpense_4a4e2d76-810e-43b7-baec-c801c91dd5f4" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_sgfy_UnallocatedCostsAndExpenses_5bb0015e-bcdd-48e0-8a3a-d40033883c73" xlink:href="sgfy-20210331.xsd#sgfy_UnallocatedCostsAndExpenses"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_a29fe631-7601-4a86-9491-1db83a2bf285" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
<link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sgfy_UnallocatedCostsAndExpenses_5bb0015e-bcdd-48e0-8a3a-d40033883c73" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_a29fe631-7601-4a86-9491-1db83a2bf285" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_6edff931-80bf-4fc7-9314-dd687264bd35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
<link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sgfy_UnallocatedCostsAndExpenses_5bb0015e-bcdd-48e0-8a3a-d40033883c73" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_6edff931-80bf-4fc7-9314-dd687264bd35" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_d769ef7d-8513-49ef-93fc-4790e11832ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
<link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sgfy_UnallocatedCostsAndExpenses_5bb0015e-bcdd-48e0-8a3a-d40033883c73" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_d769ef7d-8513-49ef-93fc-4790e11832ee" xlink:type="arc"/>
<link:loc xlink:type="locator" xlink:label="loc_sgfy_NonAllocatedCostsAndExpenses_d4a957ec-93c4-4236-aa84-b34dd669c90f" xlink:href="sgfy-20210331.xsd#sgfy_NonAllocatedCostsAndExpenses"/>
<link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sgfy_UnallocatedCostsAndExpenses_5bb0015e-bcdd-48e0-8a3a-d40033883c73" xlink:to="loc_sgfy_NonAllocatedCostsAndExpenses_d4a957ec-93c4-4236-aa84-b34dd669c90f" xlink:type="arc"/>
</link:calculationLink>
<link:roleRef roleURI="http://signifyhealth.com/role/Concentrations" xlink:type="simple" xlink:href="sgfy-20210331.xsd#Concentrations"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/Concentrations" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/ConcentrationsDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#ConcentrationsDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/ConcentrationsDetails" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="sgfy-20210331.xsd#RelatedPartyTransactions"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/RelatedPartyTransactions" xlink:type="extended"/>
<link:roleRef roleURI="http://signifyhealth.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="sgfy-20210331.xsd#RelatedPartyTransactionsDetails"/>
<link:calculationLink xlink:role="http://signifyhealth.com/role/RelatedPartyTransactionsDetails" xlink:type="extended"/>
</link:linkbase>

↑Top
Filing Submission 0001828182-21-000017   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Mon., Apr. 29, 2:17:18.2pm ET